Description | 7C4 is a neutralizing antibody targeting the RT of HIV-1, derived from mouse. 7C4 interferes with the interaction between RT and the template primer and strongly inhibits the RNA-dependent polymerase activity of HIV-1 RT. This product has been determined by Enzyme-linked immunosorbent assay, Surface plasmon resonance and Inhibition assay. |
Clonality | Monoclonal |
Host Species | Mouse |
Target Species | HIV-1 (IIIB, Bru and IMS-1) |
Immunogen | Infectious vaccinia virus recombinant (WRRT) expressing the RT of HIV-1 |
Epitope | The epitope recognized by 7C4 exists in the region of the template primer-binding sites (or the 'helix clump') of RT. |
IC50 | 42 nM |
Isotype | Mouse IgG |
Expression Species | HEK293F or CHO cell line |
Conjugation | Unconjugated |
Purity | >95% |
Endotoxin | <1 EU/mg |
Form | Liquid |
Purification | Protein G purified |
Sterility | 0.2 μM filtered |
Formulation | PBS, pH 7.4 |
Preservation | No preservatives |
Stabilizer | No stabilizers |
Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
Application | ELISA; SPR; Inhib |
Application Notes | ELISA: After washing, 50 µl of 2 µg/mL IgG was added to each well and incubated for 1 h. Surface plasmon resonance (SPR): The resonance unit from the chip incubated with different concentrations of antibody after washing with HBS buffer was recorded. Inhibition assay: 7C4 Fab fragments induced 95% inhibition of RT activity at 400 nM. |
ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
WB | Western Blot Protocol |
FC | Flow Cytometry Protocol |
Target | HIV-1 RT |
Alternative Name | Human immunodeficiency virus type 1 reverse transcriptase |
Research Area | Infectious Disease |
Related Disease | Acquired Immune Deficiency Syndrome |